The skin’s epidermis is an essential barrier as the first guard against invading pathogens, and physical protector from external
injury. The skin microbiome, which consists of numerous bacteria, fungi, viruses, and archaea on the epidermis, play a key
role in skin homeostasis. Antibiotics are a fast-acting and effective treatment method, however, antibiotic use is a nuisance
that can disrupt skin homeostasis by eradicating beneficial bacteria along with the intended pathogens and cause antibioticresistant
bacteria spread. Increased numbers of antimicrobial peptides (AMPs) derived from humans and bacteria have been
reported, and their roles have been well defined. Recently, modulation of the skin microbiome with AMPs rather than artificially
synthesized antibiotics has attracted the attention of researchers as many antibiotic-resistant strains make treatment
mediation difficult in the context of ecological problems. Herein, we discuss the overall insights into the skin microbiome,
including its regulation by different AMPs, as well as their composition and role in health and disease.
Citations
Citations to this article as recorded by
The epidermal lipid-microbiome loop and immunity: Important players in atopic dermatitis Junchao Wu, Lisha Li, Tingrui Zhang, Jiaye Lu, Zongguang Tai, Quangang Zhu, Zhongjian Chen Journal of Advanced Research.2025; 68: 359. CrossRef
Marine algal polysaccharides: Multifunctional bioactive ingredients for cosmetic formulations Si-Yuan Lu, Tao Zhou, Iqra Shabbir, Jaehwan Choi, Young Heui Kim, Myeongsam Park, Jude Juventus Aweya, Karsoon Tan, Saiyi Zhong, Kit-Leong Cheong Carbohydrate Polymers.2025; 353: 123276. CrossRef
A review on pathogenicity of Aeromonas hydrophila and their mitigation through medicinal herbs in aquaculture Anurag Semwal, Avdhesh Kumar, Neelesh Kumar Heliyon.2023; 9(3): e14088. CrossRef
Fırtına Deresindeki Gökkuşağı Alabalık Çiftliklerinde İzole Edilen Aeromonas spp. İzolatlarının Antimikrobiyel Hassasiyetin Belirlenmesi Fikri BALTA Journal of Anatolian Environmental and Animal Sciences.2020; 5(3): 397. CrossRef
Monitoring microbial community structure and succession of an A/O SBR during start-up period using PCR-DGGE Xiuheng WANG, Kun ZHANG, Nanqi REN, Nan LI, Lijiao REN Journal of Environmental Sciences.2009; 21(2): 223. CrossRef
We employed a stepwise selection model for investigating the
dynamics of antibiotic-resistant variants in Escherichia coli
K-12 treated with increasing concentrations of ciprofloxacin
(CIP). Firstly, we used Sanger sequencing to screen the variations
in the fluoquinolone target genes, then, employed Illumina
NGS sequencing for amplicons targeted regions with
variations. The results demonstrated that variations G81C in
gyrA and K276N and K277L in parC are standing resistance
variations (SRVs), while S83A and S83L in gyrA and G78C
in parC were emerging resistance variations (ERVs). The variants
containing SRVs and/or ERVs were selected successively
based on their sensitivities to CIP. Variant strain 1, containing
substitution G81C in gyrA, was immediately selected
following ciprofloxacin exposure, with obvious increases in
the parC SRV, and parC and gyrA ERV allele frequencies.
Variant strain 2, containing the SRVs, then dominated the
population following a 20× increase in ciprofloxacin concentration,
with other associated allele frequencies also elevated.
Variant strains 3 and 4, containing ERVs in gyrA and parC,
respectively, were then selected at 40× and 160× antibiotic
concentrations. Two variants, strains 5 and 6, generated in
the selection procedure, were lost because of higher fitness
costs or a lower level of resistance compared with variants 3
and 4. For the second induction, all variations/indels were
already present as SRVs and selected out step by step at different
passages. Whatever the first induction or second induction,
our results confirmed the soft selective sweep hypothesis
and provided critical information for guiding clinical
treatment of pathogens containing SRVs.
Citations
Citations to this article as recorded by
Could traces of fluoroquinolones in food induce ciprofloxacin resistance in
Escherichia coli
and
Klebsiella pneumoniae
? An
in vivo
study in
Galleria mellonel Zina Gestels, Yuliia Baranchyk, Dorien Van den Bossche, Jolein Laumen, Said Abdellati, Basil Britto Xavier, Sheeba Santhini Manoharan-Basil, Chris Kenyon, Sadjia Bekal, Mustafa Sadek Microbiology Spectrum.2024;[Epub] CrossRef
The yeast Candida albicans is a member of the microbiota
in the gastrointestinal and urogenital tracts of most healthy
persons, but it can also cause symptomatic infections, especially
in immunocompromised patients. During the life-long
association with its human host, C. albicans generates genetically
altered variants that are better adapted to changes in
their environment. A prime example of this microevolution
is the development of resistance to the commonly used drug
fluconazole, which inhibits ergosterol biosynthesis, during
antimycotic therapy. Fluconazole resistance can be caused by
mutations in the drug target, by changes in the sterol biosynthesis
pathway, and by gain-of-function mutations in transcription
factors that result in the constitutive upregulation
of ergosterol biosynthesis genes and multidrug efflux pumps.
Fluconazole also induces genomic rearrangements that result
in gene amplification and loss of heterozygosity for resistance
mutations, which further increases drug resistance.
These genome alterations may affect extended chromosomal
regions and have additional phenotypic consequences. A
striking case is the loss of heterozygosity for the mating type
locus MTL in many fluconazole-resistant clinical isolates,
which allows the cells to switch to the mating-competent opaque
phenotype. This, in turn, raises the possibility that sexual
recombination between different variants of an originally clonal,
drug-susceptible population may contribute to the generation
of highly fluconazole-resistant strains with multiple
resistance mechanisms. The gain-of-function mutations in
transcription factors, which result in deregulated gene expression,
also cause reduced fitness. In spite of this, many clinical
isolates that contain such mutations do not exhibit fitness defects,
indicating that they have overcome the costs of drug
resistance with further evolution by still unknown mechanisms.
Citations
Citations to this article as recorded by
Structural, physicochemical characterization and antimicrobial activities of a new tris(8-quinolinolato-κ2N,O)cobalt(III) ethanol solvate [Co(C9H6NO)3].(C2H6O) Salsabil Idoudi, Badiaa Essghaier, Mohamed Faouzi Zid, Saoussen Namouchi Cherni Journal of Molecular Structure.2024; 1296: 136848. CrossRef
Adaptation of Candida albicans to specific host environments by gain-of-function mutations in transcription factors Joachim Morschhäuser, Aaron P. Mitchell PLOS Pathogens.2024; 20(11): e1012643. CrossRef
The
Neosartorya (Aspergillus) fischeri
antifungal protein NFAP2 has low potential to trigger resistance development in
Candida albicans in vitro
Gábor Bende, Nóra Zsindely, Krisztián Laczi, Zsolt Kristóffy, Csaba Papp, Attila Farkas, Liliána Tóth, Szabolcs Sáringer, László Bodai, Gábor Rákhely, Florentine Marx, László Galgóczy, Gustavo H. Goldman, Norman van Rhijn Microbiology Spectrum.2024;[Epub] CrossRef
The TAC1 Gene in Candida albicans: Structure, Function, and Role in Azole Resistance: A Mini-Review Amir Hossein Mahdizade, Akbar Hoseinnejad, Mona Ghazanfari, Mohammad Javad Boozhmehrani, Seyed Sobhan Bahreiny, Mahdi Abastabar, Roberta Galbo, Letterio Giuffrè, Iman Haghani, Orazio Romeo Microbial Drug Resistance.2024; 30(7): 288. CrossRef
Boric Acid for the Treatment of Vaginitis: New Possibilities Using an Old Anti‐Infective Agent: A Systematic Review Matilde Lærkeholm Müller, Christina Damsted Petersen, Ditte Marie L. Saunte, Althea East-Innis Dermatologic Therapy.2024;[Epub] CrossRef
Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis Jyoti Sankar Prusty, Ashwini Kumar, Awanish Kumar Critical Reviews in Microbiology.2024; : 1. CrossRef
Microevolution during Chronic Infection May Lead T. asahii to Coexist with the Host Gen Ba, Xuelian Lv, Xin Yang, Wenling Wang, Junhong Ao, Rongya Yang, Ioannis D. Bassukas Dermatology Research and Practice.2024;[Epub] CrossRef
Cluster analysis allowed to identify antifungal drugs that retain efficacy against Candida albicans isolated from patients with inflammatory diseases of the soft tissues of the maxillofacial area Mariia Faustova, Volodymyr Dobrovolskyi, Galina Loban’, Yevhenii Bereza, Aleksandra Kotelnikova, Oleksandr Dobrovolskyi Frontiers in Oral Health.2024;[Epub] CrossRef
Two different types of tandem sequences mediate the overexpression of
TinCYP51B
in azole-resistant
Trichophyton indotineae
Tsuyoshi Yamada, Mari Maeda, Hiroaki Nagai, Karine Salamin, Yun-Tsan Chang, Emmanuella Guenova, Marc Feuermann, Michel Monod, Andreas H. Groll Antimicrobial Agents and Chemotherapy.2023;[Epub] CrossRef
Anticandidal activity of nanocomposite based on nanochitosan, nanostarch and mycosynthesized copper oxide nanoparticles against multidrug-resistant Candida Mohamed Saied, Mohamed Hasanin, Tarek M. Abdelghany, Basma H. Amin, Amr H. Hashem International Journal of Biological Macromolecules.2023; 242: 124709. CrossRef
Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection Vinicius Alves, Pedro Henrique Martins, Bruna Miranda, Iara Bastos de Andrade, Luiza Pereira, Christina Takiya Maeda, Glauber Ribeiro de Sousa Araújo, Susana Frases Journal of Fungi.2023; 9(8): 783. CrossRef
Detrimental consequences of tebuconazole on redox homeostasis and fatty acid profile of honeybee brain Máté Mackei, Csilla Sebők, Júlia Vöröházi, Patrik Tráj, Fruzsina Mackei, Barnabás Oláh, Hedvig Fébel, Zsuzsanna Neogrády, Gábor Mátis Insect Biochemistry and Molecular Biology.2023; 159: 103990. CrossRef
Benzamidine Conjugation Converts Expelled Potential Active Agents into Antifungals against Drug-Resistant Fungi Xue Wang, Xueyang Jin, Zhiyu Xie, Hongyang Zhang, Tiantian Liu, Hongbo Zheng, Xiaoyi Luan, Yan Sun, Wenjie Fang, Wenqiang Chang, Hongxiang Lou Journal of Medicinal Chemistry.2023; 66(19): 13684. CrossRef
Advances in efficacy enhancement of photosensitizer-mediated photodynamic antimicrobial chemotherapy Benard M. Isaiah, Edith K. Amuhaya, Clare I. Muhanji Journal of Porphyrins and Phthalocyanines.2023; 27(06): 819. CrossRef
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris Martina Raschig, Bernardo Ramírez‐Zavala, Johannes Wiest, Marco Saedtler, Marcus Gutmann, Ulrike Holzgrabe, Joachim Morschhäuser, Lorenz Meinel Archiv der Pharmazie.2023;[Epub] CrossRef
A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans Arome Solomon Odiba, Olanrewaju Ayodeji Durojaye, Ifeoma Maureen Ezeonu, Anthony Christian Mgbeahuruike, Bennett Chima Nwanguma Infection and Drug Resistance.2022; Volume 15: 3111. CrossRef
Metabolite profiling, antifungal, biofilm formation prevention and disruption of mature biofilm activities of Erythrina senegalensis stem bark extract against Candida albicans and Candida glabrata Benjamin Kingsley Harley, Anthony Martin Quagraine, David Neglo, Mike Okweesi Aggrey, Emmanuel Orman, Nana Ama Mireku-Gyimah, Cedric Dzidzor Amengor, Jonathan Jato, Yussif Saaka, Theophilus Christian Fleischer, Umakanta Sarker PLOS ONE.2022; 17(11): e0278096. CrossRef
Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies Emily M. Stevenson, William H. Gaze, Neil A. R. Gow, Alwyn Hart, Wiebke Schmidt, Jane Usher, Adilia Warris, Helen Wilkinson, Aimee K. Murray Frontiers in Fungal Biology.2022;[Epub] CrossRef
The Risk Factors and Mechanisms of Azole Resistance of Candida tropicalis Blood Isolates in Thailand: A Retrospective Cohort Study Teera Leepattarakit, Orawan Tulyaprawat, Popchai Ngamskulrungroj Journal of Fungi.2022; 8(10): 983. CrossRef
Antifungals and Drug Resistance Chowdhury Mobaswar Hossain, Lisa Kathleen Ryan, Meeta Gera, Sabyasachi Choudhuri, Nazmun Lyle, Kazi Asraf Ali, Gill Diamond Encyclopedia.2022; 2(4): 1722. CrossRef
Synergistic Effect of the Combination of Deferoxamine and Fluconazole
In Vitro
and
In Vivo
against Fluconazole-Resistant
Candida
Spp.
Lulu An, Jingwen Tan, Yuanyuan Wang, Siyu Liu, Yongyong Li, Lianjuan Yang Antimicrobial Agents and Chemotherapy.2022;[Epub] CrossRef
Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of Candidiasis Wuqiang Wen, Hongxuan Cao, Yunyuan Huang, Jie Tu, Chen Wan, Jian Wan, Xinya Han, Han Chen, Jiaqi Liu, Li Rao, Chen Su, Chao Peng, Chunquan Sheng, Yanliang Ren Journal of Medicinal Chemistry.2022; 65(3): 2656. CrossRef
Genome plasticity in Candida albicans: A cutting-edge strategy for evolution, adaptation, and survival Ifeanyi Elibe Mba, Emeka Innocent Nweze, Emmanuel Aniebonam Eze, Zikora Kizito Glory Anyaegbunam Infection, Genetics and Evolution.2022; 99: 105256. CrossRef
Activity of poly(methacrylic acid)-silver nanoparticles on fluconazole-resistant Candida albicans strains: Synergistic and cytotoxic effects Cecília Maria Cruz Falcão, Audrey Andrade, Vanderlan Nogueira Holanda, Regina Celia Bressan Queiroz de Figueiredo, Eulália Azevedo Ximenes, Anderson Stevens Leonidas Gomes Journal of Applied Microbiology.2022; 132(6): 4300. CrossRef
Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies Raphaëlle Youf, Max Müller, Ali Balasini, Franck Thétiot, Mareike Müller, Alizé Hascoët, Ulrich Jonas, Holger Schönherr, Gilles Lemercier, Tristan Montier, Tony Le Gall Pharmaceutics.2021; 13(12): 1995. CrossRef
Etoposide and Camptothecin Reduce Growth, Viability, the Generation of Petite Mutants, and Recognize the Active Site of DNA Topoisomerase I and II Enzymes in Candida glabrata Dulce Andrade-Pavón, Omar Gómez-García Indian Journal of Microbiology.2021; 61(3): 306. CrossRef
8-hydroxyquinoline-5-(N-4-chlorophenyl) sulfonamide and fluconazole combination as a preventive strategy for Candida biofilm in haemodialysis devices Letícia Fernandes da Rocha, Bruna Pippi, Angélica Rocha Joaquim, Saulo Fernandes de Andrade, Alexandre Meneghello Fuentefria
Journal of Medical Microbiology
.2021;[Epub] CrossRef
Genetic diversity and molecular epidemiology of Candida albicans from vulvovaginal candidiasis patients Ji-yun Tian, Yong-gang Yang, Shi Chen, Yong Teng, Xin-zheng Li Infection, Genetics and Evolution.2021; 92: 104893. CrossRef
Chronic recurrent vulvovaginitis is not only due to Candida Alicia Arechavala, Ricardo Negroni, Gabriela Santiso, Roxana Depardo, Pablo Bonvehí Revista Iberoamericana de Micología.2021; 38(3): 132. CrossRef
Systematic truncations of chromosome 4 and their responses to antifungals in Candida albicans Wasim Uddin, Darshan Dhabalia, S.M. Udaya Prakash, M. Anaul Kabir Journal of Genetic Engineering and Biotechnology.2021; 19(1): 92. CrossRef
Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration Xueyang Jin, Ming Zhang, Jinghui Lu, Ximeng Duan, Jinyao Chen, Yue Liu, Wenqiang Chang, Hongxiang Lou Journal of Advanced Research.2021; 34: 65. CrossRef
Lysinibacillus Isolate MK212927: A Natural Producer of Allylamine Antifungal ‘Terbinafine’ Sayed E. El-Sayed, Neveen A. Abdelaziz, Hosam-Eldin Hussein Osman, Ghadir S. El-Housseiny, Ahmed E. Aleissawy, Khaled M. Aboshanab Molecules.2021; 27(1): 201. CrossRef
New Approach to Antifungal Activity of Fluconazole Incorporated into the Porous 6-Anhydro-α-l-Galacto-β-d-Galactan Structures Modified with Nanohydroxyapatite for Chronic-Wound Treatments—In Vitro Evaluation Justyna Rewak-Soroczynska, Paulina Sobierajska, Sara Targonska, Agata Piecuch, Lukasz Grosman, Jaroslaw Rachuna, Slawomir Wasik, Michal Arabski, Rafal Ogorek, Rafal J. Wiglusz International Journal of Molecular Sciences.2021; 22(6): 3112. CrossRef
The phosphatome of opportunistic pathogen Candida species Krisztina Szabó, Márton Miskei, Ilona Farkas, Viktor Dombrádi Fungal Biology Reviews.2021; 35: 40. CrossRef
Azole-triphenylphosphonium conjugates combat antifungal resistance and alleviate the development of drug-resistance Xin Wang, Jun Liu, Jinyao Chen, Ming Zhang, Chuan Tian, Xiaoping Peng, Gang Li, Wenqiang Chang, Hongxiang Lou Bioorganic Chemistry.2021; 110: 104771. CrossRef
Activity of Compound Agrimony Enteritis Capsules against invasive candidiasis: Exploring the differences between traditional Chinese medicine prescriptions and its main components in the treatment of diseases Jun Li, Ze-Hua Jin, Jia-Sheng Li, Liu-Yan Su, Ying-Xian Wang, Yi Zhang, Ding-Mei Qin, Gao-Xiong Rao, Rui-Rui Wang Journal of Ethnopharmacology.2021; 277: 114201. CrossRef
Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans Eric Delarze, Ludivine Brandt, Emilie Trachsel, Marion Patxot, Claire Pralong, Fabio Maranzano, Murielle Chauvel, Mélanie Legrand, Sadri Znaidi, Marie-Elisabeth Bougnoux, Christophe d’Enfert, Dominique Sanglard Frontiers in Microbiology.2020;[Epub] CrossRef
A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of Candida auris Eva-Maria Mayr, Bernardo Ramírez-Zavala, Ines Krüger, Joachim Morschhäuser, Aaron P. Mitchell mSphere.2020;[Epub] CrossRef
Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design Brian C. Monk, Alia A. Sagatova, Parham Hosseini, Yasmeen N. Ruma, Rajni K. Wilson, Mikhail V. Keniya Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2020; 1868(3): 140206. CrossRef
Dispiropyrrolidine tethered piperidone heterocyclic hybrids with broad-spectrum antifungal activity against Candida albicans and Cryptococcus neoformans Sarah Lawson, Natarajan Arumugam, Abdulrahman I. Almansour, Raju Suresh Kumar, Shankar Thangamani Bioorganic Chemistry.2020; 100: 103865. CrossRef
Lipid composition and cell surface hydrophobicity of Candida albicans influence the efficacy of fluconazole–gentamicin treatment Jakub Suchodolski, Jakub Muraszko, Aleksandra Korba, Przemysław Bernat, Anna Krasowska Yeast.2020; 37(1): 117. CrossRef
Adaptive Laboratory Evolution of Native Torulaspora delbrueckii YCPUC10 With Enhanced Ethanol Resistance and Evaluation in Co-inoculated Fermentation Daniela Catrileo, Andrea Acuña-Fontecilla, Liliana Godoy Frontiers in Microbiology.2020;[Epub] CrossRef
Genotype, biofilm formation ability and specific gene transcripts characteristics of endodontic Enterococcus faecalis under glucose deprivation condition Yawen Liu, Yifan Ping, Yuhua Xiong, Ruyu Zhou, Fulu Xu, Juan Wang, Jin Li Archives of Oral Biology.2020; 118: 104877. CrossRef
Improved Methods of Extraction and In Vitro Evaluation of Antimicrobial Potential of Stem Bark of Terminalia arjuna Sarita Khatkar, Arun Nanda, Shahid Husain Ansari Current Biochemical Engineering.2019; 5(1): 50. CrossRef
The small GTPase Rhb1 is involved in the cell response to fluconazole inCandida albicans Yu-Wen Chen, Ying-Chieh Yeh, Hsueh-Fen Chen, Ruei-Ching Chen, Guan-Yu Lin, Yu-Ting Chen, Chung-Yu Lan FEMS Yeast Research.2019;[Epub] CrossRef
The Magnitude ofCandida albicansStress-Induced Genome Instability Results from an Interaction Between Ploidy and Antifungal Drugs Ognenka Avramovska, Meleah A Hickman G3 Genes|Genomes|Genetics.2019; 9(12): 4019. CrossRef
Cytochalasans from the Endophytic Fungus Xylaria cf. curta with Resistance Reversal Activity against Fluconazole-Resistant Candida albicans Wen-Xuan Wang, Xinxiang Lei, Hong-Lian Ai, Xue Bai, Jing Li, Juan He, Zheng-Hui Li, Yong-Sheng Zheng, Tao Feng, Ji-Kai Liu Organic Letters.2019; 21(4): 1108. CrossRef
Antifungal Activity of a Hydroethanolic Extract From Astronium urundeuva Leaves Against Candida albicans and Candida glabrata Bruna Vidal Bonifácio, Taissa Vieira Machado Vila, Isadora Fantacini Masiero, Patrícia Bento da Silva, Isabel Cristiane da Silva, Érica de Oliveira Lopes, Matheus Aparecido dos Santos Ramos, Leonardo Perez de Souza, Wagner Vilegas, Fernando Rogério Pavan, Frontiers in Microbiology.2019;[Epub] CrossRef
Dissection of the regulatory role for the N-terminal domain in Candida albicans protein phosphatase Z1 Krisztina Szabó, Zoltán Kónya, Ferenc Erdődi, Ilona Farkas, Viktor Dombrádi, Joy Sturtevant PLOS ONE.2019; 14(2): e0211426. CrossRef
The Impact of Gene Dosage and Heterozygosity on the Diploid Pathobiont Candida albicans Shen-Huan Liang, Richard J. Bennett Journal of Fungi.2019; 6(1): 10. CrossRef
Evolution of Fluconazole-Resistant Candida albicans Strains by Drug-Induced Mating Competence and Parasexual Recombination Christina Popp, Bernardo Ramírez-Zavala, Sonja Schwanfelder, Ines Krüger, Joachim Morschhäuser, Judith Berman mBio.2019;[Epub] CrossRef
Accelerated evolution at chaperone promoters among Antarctic notothenioid fishes Samuel N. Bogan, Sean P. Place BMC Evolutionary Biology.2019;[Epub] CrossRef
Elevation of cell wall chitin via Ca2+–calcineurin‐mediated PKC signaling pathway maintains the viability of Candida albicans in the absence of β‐1,6‐glucan synthesis Qi Han, Na Wang, Chaoying Pan, Yue Wang, Jianli Sang Molecular Microbiology.2019; 112(3): 960. CrossRef
Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161 Brian C. Monk, Mikhail V. Keniya, Manya Sabherwal, Rajni K. Wilson, Danyon O. Graham, Harith F. Hassan, Danni Chen, Joel D. A. Tyndall Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors Jingxiang Zhang, Liping Li, Quanzhen Lv, Lan Yan, Yan Wang, Yuanying Jiang Frontiers in Microbiology.2019;[Epub] CrossRef
Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans Isis Regina Grenier Capoci, Karina Mayumi Sakita, Daniella Renata Faria, Franciele Abigail Vilugron Rodrigues-Vendramini, Glaucia Sayuri Arita, Admilton Gonçalves de Oliveira, Maria Sueli Felipe, Bernard Maigret, Patricia de Souza Bonfim-Mendonça, Erika S Frontiers in Microbiology.2019;[Epub] CrossRef
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole J. Król, U. Nawrot, M. Bartoszewicz Journal de Mycologie Médicale.2018; 28(2): 327. CrossRef
Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor Alexandra Carreira, João Boavida Ferreira, Iliana Pereira, João Ferreira, Paulo Filipe, Ricardo Boavida Ferreira, Sara Monteiro Journal of Medical Microbiology.2018; 67(2): 198. CrossRef
Varying susceptibility of clinical and environmental Scedosporium isolates to chemical oxidative stress in conidial germination Cindy Staerck, Charlotte Godon, Jean-Philippe Bouchara, Maxime J. J. Fleury Archives of Microbiology.2018; 200(3): 517. CrossRef
Rice Defensin OsAFP1 is a New Drug Candidate against Human Pathogenic Fungi Akihito Ochiai, Kodai Ogawa, Minami Fukuda, Masahiro Ohori, Takumi Kanaoka, Takaaki Tanaka, Masayuki Taniguchi, Yoshiyuki Sagehashi Scientific Reports.2018;[Epub] CrossRef
Thiobarbiturates as potential antifungal agents to control human infections caused by Candida and Cryptococcus species Muhammad Shabeer, Luiz C. A. Barbosa, Milandip Karak, Amanda C. S. Coelho, Jacqueline A. Takahashi Medicinal Chemistry Research.2018; 27(4): 1043. CrossRef
A Case for Antifungal Stewardship Rachel A. Miller Current Fungal Infection Reports.2018; 12(1): 33. CrossRef
A Hyperactive Form of the Zinc Cluster Transcription Factor Stb5 Causes
YOR1
Overexpression and Beauvericin Resistance in Candida albicans
Bernardo Ramírez-Zavala, Hannah Manz, Frank Englert, P. David Rogers, Joachim Morschhäuser Antimicrobial Agents and Chemotherapy.2018;[Epub] CrossRef
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species J. D. Sobel, R. Sobel Expert Opinion on Pharmacotherapy.2018; 19(9): 971. CrossRef
CYP51 as drug targets for fungi and protozoan parasites: past, present and future Galina I. Lepesheva, Laura Friggeri, Michael R. Waterman Parasitology.2018; 145(14): 1820. CrossRef
TLS dependent and independent functions of DNA polymerase eta (Polη/Rad30) from Pathogenic Yeast Candida albicans Kodavati Manohar, Doureradjou Peroumal, Narottam Acharya Molecular Microbiology.2018; 110(5): 707. CrossRef
Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei A. Sharifzadeh, A.R. Khosravi, H. Shokri, H. Shirzadi Journal de Mycologie Médicale.2018; 28(2): 294. CrossRef
Fluconazole-Pyridoxine Bis-Triazolium Compounds with Potent Activity against Pathogenic Bacteria and Fungi Including Their Biofilm-Embedded Forms Marsel R. Garipov, Roman S. Pavelyev, Svetlana A. Lisovskaya, Elena V. Nikitina, Airat R. Kayumov, Alina E. Sabirova, Oksana V. Bondar, Albina G. Malanyeva, Alexander M. Aimaletdinov, Alfia G. Iksanova, Konstantin V. Balakin, Yurii G. Shtyrlin Journal of Chemistry.2017; 2017: 1. CrossRef
Bridging the Gap to Non-toxic Fungal Control: Lupinus-Derived Blad-Containing Oligomer as a Novel Candidate to Combat Human Pathogenic Fungi Ana M. Pinheiro, Alexandra Carreira, Thomas A. K. Prescott, Ricardo B. Ferreira, Sara A. Monteiro Frontiers in Microbiology.2017;[Epub] CrossRef
An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses Irene A. I. Hampe, Justin Friedman, Mira Edgerton, Joachim Morschhäuser, Julia Ruth Koehler PLOS Pathogens.2017; 13(9): e1006655. CrossRef
Antimicrobial activity of
Buchenavia tetraphylla
against
Candida albicans
strains isolated from vaginal secretions
José Robson Neves Cavalcanti Filho, Tiago Fonseca Silva, Woah Queiroz Nobre, Larissa Isabela Oliveira de Souza, Cristiane Santos Silva e Silva Figueiredo, Regina Celia Bressan Queiroz de Figueiredo, Norma Buarque de Gusmão, Márcia Vanusa Silva, Luís Cláud Pharmaceutical Biology.2017; 55(1): 1521. CrossRef
Antifungal Resistance: An Emerging Reality and A Global Challenge Dimitrios P Kontoyiannis The Journal of Infectious Diseases.2017; 216(suppl_3): S431. CrossRef
Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced
MDR1
Expression and Fluconazole Resistance
Zhongle Liu, Lawrence C. Myers Antimicrobial Agents and Chemotherapy.2017;[Epub] CrossRef
Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis Tatiana Y. Hargrove, Laura Friggeri, Zdzislaw Wawrzak, Aidong Qi, William J. Hoekstra, Robert J. Schotzinger, John D. York, F. Peter Guengerich, Galina I. Lepesheva Journal of Biological Chemistry.2017; 292(16): 6728. CrossRef
The natural compound magnolol affects growth, biofilm formation, and ultrastructure of oral Candida isolates Jawad Behbehani, Sheikh Shreaz, Mohammad Irshad, Maribassapa Karched Microbial Pathogenesis.2017; 113: 209. CrossRef
The Structure of Thymidylate Kinase from Candida albicans Reveals a Unique Structural Element Kaustubh Sinha, Gordon S. Rule Biochemistry.2017; 56(33): 4360. CrossRef
Histone Acetyltransferase Encoded by
NGG1
is Required for Morphological Conversion and Virulence of
Candida Albicans
De-Dong Li, Beth Burgwyn Fuchs, Yan Wang, Xiao-Wen Huang, Dan-Dan Hu, Yan Sun, Dong Chai, Yuan-Ying Jiang, Eleftherios Mylonakis Future Microbiology.2017; 12(16): 1497. CrossRef
Human fungal pathogens: Why should we learn? Jeong-Yoon Kim Journal of Microbiology.2016; 54(3): 145. CrossRef
Candidaspecies isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis ofCandida albicansandCandida glabratabiofilms Valentina Cataldi, Emanuela Di Campli, Paolo Fazii, Tonino Traini, Luigina Cellini, Mara Di Giulio Medical Mycology.2016; : myw126. CrossRef